| Literature DB >> 16997719 |
Jean-Pierre Y Scheerlinck1, Deanne L V Greenwood.
Abstract
The requirements for veterinary vaccines are different to those of human vaccines. Indeed, while more side effects can be tolerated in animals than in humans; there are stricter requirements in terms of cost, ease of delivery (including to wildlife), and a need to develop vaccines in species for which relatively little is known in terms of molecular immunology. By their nature particulate vaccine delivery systems are well suited to address these challenges. Here, we review particulate vaccine delivery systems, ranging from cm-sized long-distance ballistic devices to nano-bead technology for veterinary species and wildlife.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16997719 DOI: 10.1016/j.ymeth.2006.05.023
Source DB: PubMed Journal: Methods ISSN: 1046-2023 Impact factor: 3.608